SPH3127 tablet

DRUG2 trials

Sponsors

Shanghai Pharmaceuticals Holding Co., Ltd

Conditions

Drug Drug InteractionEssential Hypertension

Phase 1

Drug-drug Interaction Study of SPH3127

CompletedNCT05359055

Shanghai Pharmaceuticals Holding Co., LtdDrug Drug Interaction

Start: 2021-12-13End: 2022-01-21Updated: 2022-07-29

Phase 3

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

CompletedNCT05359068

Shanghai Pharmaceuticals Holding Co., LtdEssential Hypertension

Start: 2021-06-10End: 2023-12-26Updated: 2024-05-07

Related Papers

Efficacy and Safety of SPH3127 Tablet, a Novel Direct Renin Inhibitor, in Patients with Mild-to-Moderate Essential Hypertension: A Phase III Randomised Trial.

2026-05-21